Intravenous administration of HB to healthy adult volunteers elevated plasma HB level from 0.2 mM when fasted in the morning to 2.1 mM following the administration
The 2% and 5% topical formulations require no prescription, though higher concentrations or oral formulations fall under different regulatory categories
Approved settings: Therapy occurs in JCI-accredited hospitals, specialised clinics, or authorised mobile medical services
BPC-157 is not approved by Health Canada or the FDA for human use and remains an experimental research compound
Zheng J, Wittouck S, Salvetti E, Franz CMAP, Harris HMB, Mattarelli P et al (2020) A taxonomic note on the genus Lactobacillus : description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae